<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/83241060-3BAD-499D-BA72-380013794CC6"><gtr:id>83241060-3BAD-499D-BA72-380013794CC6</gtr:id><gtr:name>Abbott</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Molecular. Genetics &amp; Pop Health</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83241060-3BAD-499D-BA72-380013794CC6"><gtr:id>83241060-3BAD-499D-BA72-380013794CC6</gtr:id><gtr:name>Abbott</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6D638570-C739-4AF8-B1F4-BDCCA8786419"><gtr:id>6D638570-C739-4AF8-B1F4-BDCCA8786419</gtr:id><gtr:firstName>Jeremy</gtr:firstName><gtr:surname>Hall</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600429"><gtr:id>ABF07EEB-6B84-49E7-B641-3701D83E34E1</gtr:id><gtr:title>Medial temporal lobe function and associative memory formation in schizophrenia</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0600429</gtr:grantReference><gtr:abstractText>Schizophrenia is a common and severe psychiatric illness. Our work aims to understand more about the causes of this illness.
Recent studies have identified genes that are associated with risk for schizophrenia. These genes affect the cellular processes underlying learning and memory. We believe that alterations in simple learning processes can result in many of the problems seen in schizophrenia. We are therefore investigating how patients with schizophrenia and their relatives perform on basic learning tasks. We are also looking at their brain activity while carrying out these learning tasks using safe magentic resonance imaging (MRI) scanning technology to see if there are differences in brain activity between people with schizophrenia and healthy control participants.
We are in addition directly investigating how specific genes associated with schizophrenia, such as a gene called Neuregulin-1, cause the illness. In particular we are studying the effects that these genes have on brain structure and function as well as on learning processes and the development of symptoms. 
We hope that understanding more about the basic causes of schizophrenia will eventually enable entirely novel treatments to be developed for this disabling mental health illness.</gtr:abstractText><gtr:technicalSummary>Schizophrenia is a common and severe neuro-psychiatric disorder. One of the characteristic abnormalities in brain structure seen in schizophrenia is a reduction in volume of the medial temporal lobe (MTL). Reductions in MTL volume is also seen in the unaffected relatives of schizophrenic patients, suggesting that this may reflect genetic risk for the disorder. The MTL is required for associative learning underlying the formation of episodic and emotional memories, areas in which patients with schizophrenia show marked deficits. Schizophrenia susceptibility genes, such as Neuregulin-1 (NRG1) show convergent effects on molecular processes underlying associative memory formation. Furthermore studies in the local population have recently identified common variants in NRG1 associated with increased risk for schizophrenia. In this project I aim to:

(i) Investigate the performance of patients with schizophrenia and their first degree relatives in two behavioural tests of associative memory formation: face-name pair memory and Pavlovian conditioning.
(ii) Use functional magnetic imaging to investigate the activation of the MTL in patients and relatives performing these associative memory tasks.
(iii) Determine the impact of genetic variants in NRG1 on associative memory formation and MTL structure and activation.

These studies will directly investigate the basic neurobiological process of associative memory formation in schizophrenia, and will develop models in which to test the impact of genes conferring susceptibility to schizophrenia on associative memory formation. In addition this work will provide me with extensive training in the areas of functional imaging and psychiatric genetics.</gtr:technicalSummary><gtr:fund><gtr:end>2009-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>286022</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Wyeth Pharmaceuticals</gtr:department><gtr:description>Translational Medicine Research Collaboration (includes Wyeth)</gtr:description><gtr:id>EDE3B14A-CA98-483D-8E85-5D39E85B74D5</gtr:id><gtr:impact>Work undertaken as part of my MRC Fellowship has led to the establishment of 2 collaborative grants with the Translational Medicine Research Collaboration (TMRC), in which Wyeth is a major stakeholder. This work develops the potential use of neuroimaging markers of medial temporal lobe function and associative memory formation as potential biomarkers for schizophrenia and for the development of medications aimed at cognitive enhancement. This additional funding has enabled me to expand the scope of the project to include larger numbers and additional clinical groups. This will also potentially facilitate future genetic analysis of the imaging data. Combined publications include a recent paper accepted in teh Archives of General Psychiatry.</gtr:impact><gtr:outcomeId>78C1683B80D-1</gtr:outcomeId><gtr:partnerContribution>Some technical discussions</gtr:partnerContribution><gtr:piContribution>For one of the collaborative projects I was PI and designed, submitted, implemented and analysed the work. FOr the second project I was Co-I and played a major role in the design and implementation of the work..</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Pfizer Grand Challenge Project</gtr:description><gtr:id>BC724DF7-48A6-4613-815E-70ADB3D98E08</gtr:id><gtr:impact>Ongoing</gtr:impact><gtr:outcomeId>kFifHfk3i7d-1</gtr:outcomeId><gtr:partnerContribution>techincal and research input</gtr:partnerContribution><gtr:piContribution>Design, implementation and recruitment of a large imaging an d genetic collaboration.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Abbott</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Research Collaboration with Abbott Pharmaceuticals</gtr:description><gtr:id>FC832519-A24A-4288-8B5D-72E68919B762</gtr:id><gtr:impact>Collaboration ongoing</gtr:impact><gtr:outcomeId>KCVRx9fSgFB-1</gtr:outcomeId><gtr:partnerContribution>Shared knowledge</gtr:partnerContribution><gtr:piContribution>Generation of new imaging model for translational research</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Feedback to research participants</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A22C1D2B-6BE8-4BFA-876B-7CABB2BB96DC</gtr:id><gtr:impact>A large feedback meeting was held for all research participants and interested parties at which the results of the research at that stage were presented. It is intended that future such meetings will also be held.

Positive feedback from participants.</gtr:impact><gtr:outcomeId>2FBDB260D44</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>242375</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wyeth Pharmaceuticals</gtr:department><gtr:description>Translational Medicine Research Collaboration</gtr:description><gtr:fundingOrg>Pfizer Ltd</gtr:fundingOrg><gtr:id>E4D1E6E5-B67E-45E4-894A-B2B1F3E087EB</gtr:id><gtr:outcomeId>AC41B6270510</gtr:outcomeId><gtr:sector>Private</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1037764</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pfizer Grand Challenge Grant</gtr:description><gtr:fundingOrg>Pfizer Ltd</gtr:fundingOrg><gtr:id>2FA49112-B8AB-4FFE-86AC-C55F4E0B602F</gtr:id><gtr:outcomeId>Cug5Zv23kQd0</gtr:outcomeId><gtr:sector>Private</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>195646</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wyeth Pharmaceuticals</gtr:department><gtr:description>Translational Medicine Research Collaboration</gtr:description><gtr:fundingOrg>Pfizer Ltd</gtr:fundingOrg><gtr:id>33F8C414-E0F8-4D6C-A6A7-945DA885ACCA</gtr:id><gtr:outcomeId>7B8B6BA42060</gtr:outcomeId><gtr:sector>Private</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>575000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Scottish Senior Clinical Fellowship</gtr:description><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:id>C57DAD19-CD18-4DD6-A876-FEF2BB35EEA0</gtr:id><gtr:outcomeId>XFAFh721KPd0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>This is an fMRI task which assesses brain activation related to specific psychotic symptoms.</gtr:description><gtr:id>0130736B-8351-494D-8B60-9BE12D1C1207</gtr:id><gtr:impact>Ongoing research work which includes collaborations with Wyeth pharamceuticals (now Pfizer) examining potential use as a biomarker.</gtr:impact><gtr:outcomeId>F9777F89A14</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Conditioning paradigm</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8C6D94ED-8680-4B31-86A7-942B63603F74</gtr:id><gtr:title>Social cognition, the male brain and the autism spectrum.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c7983cb4f1f576b48b0d06408990a4a"><gtr:id>9c7983cb4f1f576b48b0d06408990a4a</gtr:id><gtr:otherNames>Hall J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13010_20_23300517</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78E9A7DC-5120-469B-9507-A2D86D0BD9F8</gtr:id><gtr:title>A common neural system mediating two different forms of social judgement.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c7983cb4f1f576b48b0d06408990a4a"><gtr:id>9c7983cb4f1f576b48b0d06408990a4a</gtr:id><gtr:otherNames>Hall J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>41B6A75E1C6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C2E0523-DD85-449D-84F5-0FCB9B7EA177</gtr:id><gtr:title>Genetic risk for schizophrenia: convergence on synaptic pathways involved in plasticity.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c7983cb4f1f576b48b0d06408990a4a"><gtr:id>9c7983cb4f1f576b48b0d06408990a4a</gtr:id><gtr:otherNames>Hall J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>569fb24a14a915.71674942</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D89E061-04B7-4751-B029-9553D38A6964</gtr:id><gtr:title>Prefrontal function and activation in bipolar disorder and schizophrenia.</gtr:title><gtr:parentPublicationTitle>The American journal of psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/814fc54fff9da5809e59a1dc0bb714c5"><gtr:id>814fc54fff9da5809e59a1dc0bb714c5</gtr:id><gtr:otherNames>McIntosh AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0002-953X</gtr:issn><gtr:outcomeId>8A5387A5A41</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13EE4607-F970-4E97-801A-C32C5FE1F12A</gtr:id><gtr:title>Genetic variation in CNTNAP2 alters brain function during linguistic processing in healthy individuals.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/546aab6570de14e108d67dbe21ff57d0"><gtr:id>546aab6570de14e108d67dbe21ff57d0</gtr:id><gtr:otherNames>Whalley HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>rPxeT5No4Kn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0497C89F-9B02-49F2-9B01-F749CC49927E</gtr:id><gtr:title>Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/546aab6570de14e108d67dbe21ff57d0"><gtr:id>546aab6570de14e108d67dbe21ff57d0</gtr:id><gtr:otherNames>Whalley HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>pm_13010_20_22850735</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7994A09B-73EE-408F-AB82-3F4BC6D0AB68</gtr:id><gtr:title>Midbrain activation during Pavlovian conditioning and delusional symptoms in schizophrenia.</gtr:title><gtr:parentPublicationTitle>Archives of general psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0793e339bc72df33ee6cf3ced77267b"><gtr:id>f0793e339bc72df33ee6cf3ced77267b</gtr:id><gtr:otherNames>Romaniuk L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-990X</gtr:issn><gtr:outcomeId>TVutDfJcLrA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>722D94BE-F984-419E-B3A0-CC172B20A376</gtr:id><gtr:title>The impact of substance use on brain structure in people at high risk of developing schizophrenia.</gtr:title><gtr:parentPublicationTitle>Schizophrenia bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e7a16ac837f491ab650461f39a52e2b"><gtr:id>5e7a16ac837f491ab650461f39a52e2b</gtr:id><gtr:otherNames>Welch KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0586-7614</gtr:issn><gtr:outcomeId>a25FokWxD93</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E279C452-0912-48BC-A866-35A33E31B199</gtr:id><gtr:title>Neuroticism, depressive symptoms and white-matter integrity in the Lothian Birth Cohort 1936.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/814fc54fff9da5809e59a1dc0bb714c5"><gtr:id>814fc54fff9da5809e59a1dc0bb714c5</gtr:id><gtr:otherNames>McIntosh AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>pm_13010_20_22785087</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>045438EE-4F50-42E0-AABE-2911CA67669D</gtr:id><gtr:title>The 'continuum of psychosis': scientifically unproven and clinically impractical.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5e6834ce6d5b893528624125e04a2ea"><gtr:id>d5e6834ce6d5b893528624125e04a2ea</gtr:id><gtr:otherNames>Lawrie SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>QqEdZm9qKNs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC07EC4C-94DE-429D-BED8-191BD8461984</gtr:id><gtr:title>Effects of a Balanced Translocation between Chromosomes 1 and 11 Disrupting the DISC1 Locus on White Matter Integrity.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/546aab6570de14e108d67dbe21ff57d0"><gtr:id>546aab6570de14e108d67dbe21ff57d0</gtr:id><gtr:otherNames>Whalley HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56a235157a2a39.83544122</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3CF3762-DCEB-4D6C-A5F5-B41185670F69</gtr:id><gtr:title>Effects of the BDNF val66met polymorphism on prefrontal brain function in a population at high genetic risk of schizophrenia.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/546aab6570de14e108d67dbe21ff57d0"><gtr:id>546aab6570de14e108d67dbe21ff57d0</gtr:id><gtr:otherNames>Whalley HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>DcANj2uv87u</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFC749C8-29AC-466C-BE7B-D48269D40CC8</gtr:id><gtr:title>The relationship of anterior thalamic radiation integrity to psychosis risk associated neuregulin-1 variants.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dabe0502039cc2d22e0a21f488576461"><gtr:id>dabe0502039cc2d22e0a21f488576461</gtr:id><gtr:otherNames>Sprooten E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>C518BE04CA4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4FF4ABD-FD96-4A4B-80B5-1E614C47BCD3</gtr:id><gtr:title>A GRIK4 variant conferring protection against bipolar disorder modulates hippocampal function.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/546aab6570de14e108d67dbe21ff57d0"><gtr:id>546aab6570de14e108d67dbe21ff57d0</gtr:id><gtr:otherNames>Whalley HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>3B2A7E6F079</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E1DC6F4-8C89-4766-99A7-061738AFE493</gtr:id><gtr:title>Schizophrenia copy number variants and associative learning.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d88eea34f5efbdfce018eb0abdcf1a54"><gtr:id>d88eea34f5efbdfce018eb0abdcf1a54</gtr:id><gtr:otherNames>Clifton NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>58a57840e4c0f6.09434784</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6659C617-C337-471D-924E-E09DBFE33036</gtr:id><gtr:title>White matter integrity in individuals at high genetic risk of bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dabe0502039cc2d22e0a21f488576461"><gtr:id>dabe0502039cc2d22e0a21f488576461</gtr:id><gtr:otherNames>Sprooten E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>pm_13010_20_21429475</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5449BC56-D245-4A59-B4F8-2E2D4FBFC9EB</gtr:id><gtr:title>The influence of polygenic risk for bipolar disorder on neural activation assessed using fMRI.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/546aab6570de14e108d67dbe21ff57d0"><gtr:id>546aab6570de14e108d67dbe21ff57d0</gtr:id><gtr:otherNames>Whalley HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn><gtr:outcomeId>pm_13010_20_22760554</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5051D3E3-9622-4DCB-B6CC-5F13429AFB99</gtr:id><gtr:title>Cortical thickness in first-episode schizophrenia patients and individuals at high familial risk: a cross-sectional comparison.</gtr:title><gtr:parentPublicationTitle>Schizophrenia research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dabe0502039cc2d22e0a21f488576461"><gtr:id>dabe0502039cc2d22e0a21f488576461</gtr:id><gtr:otherNames>Sprooten E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0920-9964</gtr:issn><gtr:outcomeId>pm_13010_20_24120958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F42FA1FF-D523-40CB-BA7D-8C21D8D73028</gtr:id><gtr:title>Structural abnormalities of ventrolateral and orbitofrontal cortex in patients with familial bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Bipolar disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbca2d168a7da776ff2268312de13c6a"><gtr:id>fbca2d168a7da776ff2268312de13c6a</gtr:id><gtr:otherNames>Stanfield AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1398-5647</gtr:issn><gtr:outcomeId>C386BB39774</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C25985D5-4F35-4427-A60C-498B39BB9B6C</gtr:id><gtr:title>Polygenic risk and white matter integrity in individuals at high risk of mood disorder.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/546aab6570de14e108d67dbe21ff57d0"><gtr:id>546aab6570de14e108d67dbe21ff57d0</gtr:id><gtr:otherNames>Whalley HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>pm_13010_20_23453289</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C1691F5-2770-4AC7-8A1D-825F382E1DCA</gtr:id><gtr:title>Set shifting and reversal learning in patients with bipolar disorder or schizophrenia.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f61b518871bb3b77f5077a1d8448622f"><gtr:id>f61b518871bb3b77f5077a1d8448622f</gtr:id><gtr:otherNames>McKirdy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>35970912554</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C1263BD-9526-406F-B629-B3D2A3DF80E4</gtr:id><gtr:title>Changes in gyrification over 4 years in bipolar disorder and their association with the brain-derived neurotrophic factor valine(66) methionine variant.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c4132f1e61d3eec617f9f12a991a3bb"><gtr:id>7c4132f1e61d3eec617f9f12a991a3bb</gtr:id><gtr:otherNames>Mirakhur A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>CE09B369C80</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A40186EC-0D0D-41D5-B426-2988ACD977AE</gtr:id><gtr:title>Juvenile stress produces long-lasting changes in hippocampal DISC1, GSK3&amp;szlig; and NRG1 expression.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/876a869beb8ac4b86fd92ab51af34bfc"><gtr:id>876a869beb8ac4b86fd92ab51af34bfc</gtr:id><gtr:otherNames>Brydges NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>54ee0188064f86.87862905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B96765D-E648-4510-B525-C74BDC672826</gtr:id><gtr:title>Orbitofrontal morphology in people at high risk of developing schizophrenia.</gtr:title><gtr:parentPublicationTitle>European psychiatry : the journal of the Association of European Psychiatrists</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af217e700b6b7e652f4e0f6ee480a4aa"><gtr:id>af217e700b6b7e652f4e0f6ee480a4aa</gtr:id><gtr:otherNames>Chakirova G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0924-9338</gtr:issn><gtr:outcomeId>WKUe6Qgv62X</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCA4A82C-D358-4EB7-98DB-24E2BA92E95F</gtr:id><gtr:title>The effects of DISC1 risk variants on brain activation in controls, patients with bipolar disorder and patients with schizophrenia.</gtr:title><gtr:parentPublicationTitle>Psychiatry research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af217e700b6b7e652f4e0f6ee480a4aa"><gtr:id>af217e700b6b7e652f4e0f6ee480a4aa</gtr:id><gtr:otherNames>Chakirova G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0165-1781</gtr:issn><gtr:outcomeId>pm_13010_20_21376542</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7088AE7E-F311-4C10-9103-40EAEB84AE27</gtr:id><gtr:title>The effects of a neuregulin 1 variant on white matter density and integrity.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/814fc54fff9da5809e59a1dc0bb714c5"><gtr:id>814fc54fff9da5809e59a1dc0bb714c5</gtr:id><gtr:otherNames>McIntosh AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>22E3B43A1B6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA427ABB-C005-4F35-B149-D56A25EC0C3F</gtr:id><gtr:title>Functional Magnetic Resonance Imaging (fMRI) reproducibility and variance components across visits and scanning sites with a finger tapping task.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5db7ab21ef511826e2a8245b616b20f"><gtr:id>d5db7ab21ef511826e2a8245b616b20f</gtr:id><gtr:otherNames>Gountouna VE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>5002454B707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32AD6A71-46CE-44DC-B7DE-DFA670D370BC</gtr:id><gtr:title>White matter abnormalities in bipolar disorder and schizophrenia detected using diffusion tensor magnetic resonance imaging.</gtr:title><gtr:parentPublicationTitle>Bipolar disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bee2ac19654f8b2cac08d40a05f8214b"><gtr:id>bee2ac19654f8b2cac08d40a05f8214b</gtr:id><gtr:otherNames>Sussmann JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1398-5647</gtr:issn><gtr:outcomeId>0C0AE414A0A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF1693E8-CE2A-4384-9911-CC077B299281</gtr:id><gtr:title>Childhood adversity and hippocampal and amygdala volumes in a population at familial high risk of schizophrenia.</gtr:title><gtr:parentPublicationTitle>Schizophrenia research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7906e1b0e03aacb676ed3390cd56635f"><gtr:id>7906e1b0e03aacb676ed3390cd56635f</gtr:id><gtr:otherNames>Barker V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0920-9964</gtr:issn><gtr:outcomeId>5a6dc8b00b6d50.29548737</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95609A26-93CC-404C-89E5-4A6704304FE0</gtr:id><gtr:title>Identification of common variants associated with human hippocampal and intracranial volumes.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e9f254d9d808af1a43ce46fce3a313e"><gtr:id>9e9f254d9d808af1a43ce46fce3a313e</gtr:id><gtr:otherNames>Stein JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_13010_20_22504417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BBFCFC4-CC96-4AD3-9EF1-B9B8C392137A</gtr:id><gtr:title>Association of white matter integrity with genetic variation in an exonic DISC1 SNP.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dabe0502039cc2d22e0a21f488576461"><gtr:id>dabe0502039cc2d22e0a21f488576461</gtr:id><gtr:otherNames>Sprooten E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>tHDP5HsfP1v</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>519DFDC7-48BC-4059-8FCF-E42E34A26A9A</gtr:id><gtr:title>Functional imaging of emotional memory in bipolar disorder and schizophrenia.</gtr:title><gtr:parentPublicationTitle>Bipolar disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/546aab6570de14e108d67dbe21ff57d0"><gtr:id>546aab6570de14e108d67dbe21ff57d0</gtr:id><gtr:otherNames>Whalley HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1398-5647</gtr:issn><gtr:outcomeId>0B0141E9371</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2D67D84-E8AF-401A-885E-616DE21B6395</gtr:id><gtr:title>Polygenic risk for schizophrenia is associated with cognitive change between childhood and old age.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/814fc54fff9da5809e59a1dc0bb714c5"><gtr:id>814fc54fff9da5809e59a1dc0bb714c5</gtr:id><gtr:otherNames>McIntosh AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>pm_13010_20_23419543</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38A03F35-2E4D-450F-B233-0398E532F1CE</gtr:id><gtr:title>White matter tractography in bipolar disorder and schizophrenia.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/814fc54fff9da5809e59a1dc0bb714c5"><gtr:id>814fc54fff9da5809e59a1dc0bb714c5</gtr:id><gtr:otherNames>McIntosh AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>913061F288D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>674641FB-72D3-4A8C-B2AA-088F8C20E7C7</gtr:id><gtr:title>Temporal grey matter reductions in bipolar disorder are associated with the BDNF Val66Met polymorphism.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/814fc54fff9da5809e59a1dc0bb714c5"><gtr:id>814fc54fff9da5809e59a1dc0bb714c5</gtr:id><gtr:otherNames>McIntosh AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>614F8E0260D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EC67DB6-6EEF-4CA8-AD8A-44E6A3C7FBCA</gtr:id><gtr:title>Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk.</gtr:title><gtr:parentPublicationTitle>Schizophrenia bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5e6834ce6d5b893528624125e04a2ea"><gtr:id>d5e6834ce6d5b893528624125e04a2ea</gtr:id><gtr:otherNames>Lawrie SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0586-7614</gtr:issn><gtr:outcomeId>CFCA23ECDF6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1166692D-8A33-41F8-B5F3-FBD98823FE9B</gtr:id><gtr:title>Neuroimaging and molecular genetics of schizophrenia: pathophysiological advances and therapeutic potential.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5e6834ce6d5b893528624125e04a2ea"><gtr:id>d5e6834ce6d5b893528624125e04a2ea</gtr:id><gtr:otherNames>Lawrie SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>5A10211C9DF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3232F569-651F-4EAC-AF82-AF6525EBD828</gtr:id><gtr:title>Progressive gray matter loss in patients with bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c741ae247b11f92e1bd54669e4d8d85"><gtr:id>3c741ae247b11f92e1bd54669e4d8d85</gtr:id><gtr:otherNames>Moorhead TW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>88DDBE06876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DF978A9-7812-418F-B873-2589D0A6886F</gtr:id><gtr:title>Schizophrenia risk genes: Implications for future drug development and discovery.</gtr:title><gtr:parentPublicationTitle>Biochemical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ca3d73365a98686b74c8a44f7b7a936"><gtr:id>1ca3d73365a98686b74c8a44f7b7a936</gtr:id><gtr:otherNames>O'Connell G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-2952</gtr:issn><gtr:outcomeId>XcFYXYWUHG8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>653A1012-CD55-4DBC-8E9F-42F4ED1DAD80</gtr:id><gtr:title>Genetic variation in the DAOA (G72) gene modulates hippocampal function in subjects at high risk of schizophrenia.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c7983cb4f1f576b48b0d06408990a4a"><gtr:id>9c7983cb4f1f576b48b0d06408990a4a</gtr:id><gtr:otherNames>Hall J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>8C3CF7888EB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D779466A-1C73-4A4A-9893-B4E511D7BBD4</gtr:id><gtr:title>Social cognition in schizophrenia: a review of face processing.</gtr:title><gtr:parentPublicationTitle>British medical bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1e0100fd6ea585b7fe74daa431f6251"><gtr:id>e1e0100fd6ea585b7fe74daa431f6251</gtr:id><gtr:otherNames>Marwick K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-1420</gtr:issn><gtr:outcomeId>54C52642DF5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16872826-6B38-4DB9-B15E-FAD4DC392AA8</gtr:id><gtr:title>Genetic variation in the G72 (DAOA) gene affects temporal lobe and amygdala structure in subjects affected by bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Bipolar disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3b3b3cc72862112bbca3064e5781813"><gtr:id>b3b3b3cc72862112bbca3064e5781813</gtr:id><gtr:otherNames>Zuliani R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1398-5647</gtr:issn><gtr:outcomeId>80D2A813600</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62CCCFC3-48B9-4B2B-9AB0-9E12D7D0C18D</gtr:id><gtr:title>Hippocampal function in schizophrenia and bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c7983cb4f1f576b48b0d06408990a4a"><gtr:id>9c7983cb4f1f576b48b0d06408990a4a</gtr:id><gtr:otherNames>Hall J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>882D8D720EE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0682537F-A8EE-42C2-AD22-4B2FE965A040</gtr:id><gtr:title>Lower effective connectivity between amygdala and parietal regions in response to fearful faces in schizophrenia.</gtr:title><gtr:parentPublicationTitle>Schizophrenia research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdc26ab89561b35597e087fa2b2b2b44"><gtr:id>fdc26ab89561b35597e087fa2b2b2b44</gtr:id><gtr:otherNames>Mukherjee P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0920-9964</gtr:issn><gtr:outcomeId>pm_13010_20_22019361</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4555BF2D-597B-486E-92D3-389C503F439F</gtr:id><gtr:title>Genome-wide association analysis identifies 13 new risk loci for schizophrenia.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c8d6984e5c8a907d8380f687ccba0dd"><gtr:id>9c8d6984e5c8a907d8380f687ccba0dd</gtr:id><gtr:otherNames>Ripke S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_13010_20_23974872</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>996B0902-689B-49F7-8903-A116DDB65267</gtr:id><gtr:title>Associative learning and the genetics of schizophrenia.</gtr:title><gtr:parentPublicationTitle>Trends in neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c7983cb4f1f576b48b0d06408990a4a"><gtr:id>9c7983cb4f1f576b48b0d06408990a4a</gtr:id><gtr:otherNames>Hall J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0166-2236</gtr:issn><gtr:outcomeId>224AF86867A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90579600-CDF4-4ADF-88A3-04DB2D4DAB71</gtr:id><gtr:title>Prefrontal gyral folding and its cognitive correlates in bipolar disorder and schizophrenia.</gtr:title><gtr:parentPublicationTitle>Acta psychiatrica Scandinavica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/814fc54fff9da5809e59a1dc0bb714c5"><gtr:id>814fc54fff9da5809e59a1dc0bb714c5</gtr:id><gtr:otherNames>McIntosh AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0001-690X</gtr:issn><gtr:outcomeId>BFA185E1998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B68E24D-0699-4159-849A-C4B8058F35FF</gtr:id><gtr:title>Effects of a mis-sense DISC1 variant on brain activation in two cohorts at high risk of bipolar disorder or schizophrenia.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/546aab6570de14e108d67dbe21ff57d0"><gtr:id>546aab6570de14e108d67dbe21ff57d0</gtr:id><gtr:otherNames>Whalley HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>pm_13010_20_22337479</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC8AE3A7-5400-4A39-9A52-49F9CDC56EDB</gtr:id><gtr:title>The neural basis of familial risk and temperamental variation in individuals at high risk of bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/546aab6570de14e108d67dbe21ff57d0"><gtr:id>546aab6570de14e108d67dbe21ff57d0</gtr:id><gtr:otherNames>Whalley HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>pm_13010_20_21601834</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC9B9AF5-BCD3-4634-A970-ECF43DFC7218</gtr:id><gtr:title>The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data.</gtr:title><gtr:parentPublicationTitle>Brain imaging and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/545bcb850f5bee6c4b4bb77b4df4cf03"><gtr:id>545bcb850f5bee6c4b4bb77b4df4cf03</gtr:id><gtr:otherNames>Thompson PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1931-7557</gtr:issn><gtr:outcomeId>56a2351619d6f7.60519506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B50D341-B959-40B2-9D37-6D111D3288DE</gtr:id><gtr:title>White matter integrity as an intermediate phenotype: exploratory genome-wide association analysis in individuals at high risk of bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Psychiatry research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dabe0502039cc2d22e0a21f488576461"><gtr:id>dabe0502039cc2d22e0a21f488576461</gtr:id><gtr:otherNames>Sprooten E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0165-1781</gtr:issn><gtr:outcomeId>pm_13010_20_23218918</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED3C0EFE-7B30-4A19-98CB-0BB4A5391297</gtr:id><gtr:title>An investigation of a genomewide supported psychosis variant in ZNF804A and white matter integrity in the human brain.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dabe0502039cc2d22e0a21f488576461"><gtr:id>dabe0502039cc2d22e0a21f488576461</gtr:id><gtr:otherNames>Sprooten E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0730-725X</gtr:issn><gtr:outcomeId>pm_13010_20_22840435</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B125334-806A-404A-B85A-98D346D22CC4</gtr:id><gtr:title>Connecting the brain and new drug targets for schizophrenia.</gtr:title><gtr:parentPublicationTitle>Current pharmaceutical design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/546aab6570de14e108d67dbe21ff57d0"><gtr:id>546aab6570de14e108d67dbe21ff57d0</gtr:id><gtr:otherNames>Whalley HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1381-6128</gtr:issn><gtr:outcomeId>CB5F3A927FB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F20DBD3-1758-4215-98E5-7B3F3F9656BC</gtr:id><gtr:title>Prediction of depression in individuals at high familial risk of mood disorders using functional magnetic resonance imaging.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/546aab6570de14e108d67dbe21ff57d0"><gtr:id>546aab6570de14e108d67dbe21ff57d0</gtr:id><gtr:otherNames>Whalley HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13010_20_23483904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4FCBB5E-F13A-437E-963C-F5847A6B1C74</gtr:id><gtr:title>Deficits in facial, body movement and vocal emotional processing in autism spectrum disorders.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e79b7b427d837240a3acccf1a1605c52"><gtr:id>e79b7b427d837240a3acccf1a1605c52</gtr:id><gtr:otherNames>Philip RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn><gtr:outcomeId>JChjkR7Bk7F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>384738D6-7EC5-43B8-9F48-EB813ECD6D65</gtr:id><gtr:title>Progress in imaging the effects of psychosis susceptibility gene variants.</gtr:title><gtr:parentPublicationTitle>Expert review of neurotherapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3ef98b38ab7a07721d6c87e81473c0b"><gtr:id>c3ef98b38ab7a07721d6c87e81473c0b</gtr:id><gtr:otherNames>Redpath HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1473-7175</gtr:issn><gtr:outcomeId>pm_13010_20_23253390</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D9D66CE-BCD5-40FB-87FA-E4BE42BAF760</gtr:id><gtr:title>Emotional memory in schizophrenia.</gtr:title><gtr:parentPublicationTitle>Neuropsychologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c7983cb4f1f576b48b0d06408990a4a"><gtr:id>9c7983cb4f1f576b48b0d06408990a4a</gtr:id><gtr:otherNames>Hall J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-3932</gtr:issn><gtr:outcomeId>44868B61195</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F173B620-3AA8-4DB8-AF53-BAE2A7D0D069</gtr:id><gtr:title>Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia?</gtr:title><gtr:parentPublicationTitle>World psychiatry : official journal of the World Psychiatric Association (WPA)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5e6834ce6d5b893528624125e04a2ea"><gtr:id>d5e6834ce6d5b893528624125e04a2ea</gtr:id><gtr:otherNames>Lawrie SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1723-8617</gtr:issn><gtr:outcomeId>pm_13010_20_21379347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9385E6E3-5BA5-4D49-BD99-F3D25845A32C</gtr:id><gtr:title>Overactivation of fear systems to neutral faces in schizophrenia.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c7983cb4f1f576b48b0d06408990a4a"><gtr:id>9c7983cb4f1f576b48b0d06408990a4a</gtr:id><gtr:otherNames>Hall J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>27799456108</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAA75774-A582-4D14-8901-5401E902F32F</gtr:id><gtr:title>Functional magnetic resonance imaging of BDNF val66met polymorphism in unmedicated subjects at high genetic risk of schizophrenia performing a verbal memory task.</gtr:title><gtr:parentPublicationTitle>Psychiatry research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfab06d272bf1c41ab1a1fc0c3077b68"><gtr:id>cfab06d272bf1c41ab1a1fc0c3077b68</gtr:id><gtr:otherNames>Baig BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0165-1781</gtr:issn><gtr:outcomeId>APcfoqd14nq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>184007AB-B240-4990-A508-59C38D88A1CF</gtr:id><gtr:title>Genetic variants in the ErbB4 gene are associated with white matter integrity.</gtr:title><gtr:parentPublicationTitle>Psychiatry research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3b3b3cc72862112bbca3064e5781813"><gtr:id>b3b3b3cc72862112bbca3064e5781813</gtr:id><gtr:otherNames>Zuliani R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0165-1781</gtr:issn><gtr:outcomeId>egSkgYMVCmj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7B196F7-A26C-416A-B5A5-B9BB8C91AA08</gtr:id><gtr:title>Altered amygdala connectivity within the social brain in schizophrenia.</gtr:title><gtr:parentPublicationTitle>Schizophrenia bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdc26ab89561b35597e087fa2b2b2b44"><gtr:id>fdc26ab89561b35597e087fa2b2b2b44</gtr:id><gtr:otherNames>Mukherjee P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0586-7614</gtr:issn><gtr:outcomeId>pm_13010_20_23851067</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F7D4FDD-FD9D-4000-B158-7B5530F49B68</gtr:id><gtr:title>A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c7983cb4f1f576b48b0d06408990a4a"><gtr:id>9c7983cb4f1f576b48b0d06408990a4a</gtr:id><gtr:otherNames>Hall J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>2217343145E</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600429</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>2472941E-25F2-45EC-A735-3C0872CE6B26</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.3  Psychological, social and economic factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>